AzTrials
AzTrials

Multiple Closed Pelvic Fractures With Disruption of Pelvic RingPIVOT-LC1-PiNCT06496867

Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis

A study testing Early Internal Fixation and Nonoperative Care with Early Rehabilitation in people with Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring and Fragility Fracture, run by University of Southern California at 13 sites in 2 countries.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy lateral compression type 1 (LC1) pelvis fracture with <10 mm initial displacement of the posterior pelvic ring… Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Early Internal Fixation and Nonoperative Care with Early Rehabilitation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
13 sitesin 2 countries
Study dates
12 Nov 2024to 31 Dec 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient 60 years of age or older.
  • Low energy injury mechanism defined as a fall from standing height.
  • LC1 pelvis fracture (AO/OTA 61B1.1 or 61B2.1) confirmed with antero-posterior, inlet, and outlet pelvis radiographs, computed tomography, or magnetic resonance imaging.
  • Fracture pattern that could be, in the judgment of the attending surgeon, managed with either early internal fixation or nonoperative care with early rehabilitation.
  • Fracture displacement of <10 mm of the posterior pelvic ring on computed tomography of the pelvis.
  • Injury occurred within 21 days of screening.

Who cannot join

  • Patient did not ambulate prior to injury.
  • Patient has another condition, injury, or fracture that prevents post-operative weightbearing on any extremity.
  • Retained implants around the pelvis that precludes or limits either study treatment.
  • Infection around the hip (soft tissue or bone).
  • Pathologic fracture with a lytic lesion in the pelvis or sacrum that precludes internal fixation.
  • Patient is too ill, in the judgement of the attending surgeon, for internal fixation.
Show all 17Show fewer
  • Patient is too ill, in the judgement of the attending surgeon, for nonoperative care.
  • Problems, in the judgment of study personnel, with maintaining follow-up with the patient.
  • Expected injury survival of less than 12 months.
  • Terminal illness with expected survival of less than 12 months.
  • Currently enrolled in a study that does not permit co-enrollment.
  • Prior enrollment in the trial.
  • Unable to obtain informed consent due to language barriers.
  • Unable to obtain informed consent because a legally authorized representative (LAR) was unavailable.
  • Did not provide informed consent (declined participation).
  • Patient or LAR not approached to participate in the trial (missed patient).
  • Other reason to exclude the patient, as approved by the Methods Centre.

Trial locations and contacts

13 sites in 2 countries.

13 sites in 2 countries

United States12 sites
  • University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center

    Baltimore, Maryland, 21201

  • Indiana University

    Bloomington, Indiana, 47405

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

  • The Curators of the University of Missouri - Missouri Orthopaedic Institute

    Columbia, Missouri, 65201

  • Keck Medical Center of USC

    Los Angeles, California, 90033

  • Los Angeles General Medical Center

    Los Angeles, California, 90033

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048

  • University of Arizona

    Phoenix, Arizona, 85006

  • University of California, Davis

    Sacramento, California, 95817

  • University of Utah

    Salt Lake City, Utah, 84112

  • University of California San Francisco

    San Francisco, California, 94143

  • University of Washington - Harborview Medical Center

    Seattle, Washington, 98104

Other trials in United States

Spain1 site
  • Research Institute Vall d'Hebrón - Vall d'Hebron University Hospital

    Barcelona, Spain, 08035

Other trials in Spain

About this study

Official title: Multicenter Randomized Controlled Trial Comparing Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis: A Pilot Study

The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy lateral compression type 1 (LC1) pelvis fracture with <10 mm initial displacement of the posterior pelvic ring will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, early internal fixation or nonoperative care with early rehabilitation, defined as at least five days of attempted mobilization by rehabilitation providers. Participants will be followed for 1 year.

Read the detailed description

More than half of fragility fractures of the pelvis in older adults exhibit a lateral compression type 1 fracture pattern (LC1), with fractures of the posterior pelvic ring involving the sacrum bone and a corresponding disruption of the anterior pelvic ring. Nonoperative treatment has remained the standard of care for older adults with minimally displaced (<10 mm) LC1 fragility fractures of the pelvis, as patients are often able to mobilize within a few days with a walking aid. However, preliminary data have suggested that early internal fixation may lead to better patient outcomes, including improved ambulation, shorter hospital stay, less use of opioid pain medication, greater likelihood of returning home after hospital admission, and a lower risk of death compared to nonoperative care. While the preliminary data supporting the use of early internal fixation for minimally displaced LC1 fragility fractures of the pelvis is promising, the necessary evidence to make this significant practice change remains lacking.

The eventual definitive trial has significant potential to change clinical practice and optimize patient outcomes for older adults who experience a minimally displaced LC1 fragility fracture of the pelvis. Treating minimally displaced LC1 fragility fractures of the pelvis with early internal fixation, instead of nonoperative care, would be a paradigm shift in clinical care. This pilot study will demonstrate feasibility of the definitive trial and be used to refine aspects of the study protocol as necessary. If feasibility is successfully demonstrated, the pilot activities will be considered a vanguard phase for the definitive clinical trial.

Adult patients ages 60 years or older with a low-energy lateral compression type 1 (LC1) pelvis fracture with <10 mm initial displacement of the posterior pelvic ring will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, early internal fixation or nonoperative care with early rehabilitation, defined as at least five days of attempted mobilization by rehabilitation providers. Patients will be followed for 1 year, with visits occurring at 2 weeks, 6 weeks, 4 months, 8 months, and 1 year after fracture. At each follow-up, mortality, ambulation, healthy days at home, and health status will be collected.

The primary objective is to assess feasibility of the trial and to collect information to inform the design of the definitive trial. The feasibility outcomes will include participant enrollment, adherence to treatment allocation, data collection methods, and compliance with key aspects of the protocol.

Being tested
Early Internal Fixation, Nonoperative Care with Early Rehabilitation
Keywords
Fragility Fracture, Lateral Compression type 1, Pelvis Fracture, Older Adults, Internal Fixation, Nonoperative Care, Physical Therapy, Early
Medical subject headings
Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Internal FixationProcedure or surgery

    Early internal fixation of the LC1 fragility fracture of the pelvis will be defined as percutaneous anterior and/or posterior pelvic internal fixation with cannulated screw(s), medullary implant(s), or sacroiliac joint fusion device(s). The implant number, design, diameter, thread type (fully-threaded or partially-threaded), sacral segment (S1, S2, S3, or any combination there of), length, trajectory including sacroiliac or transsacral-transiliac, application with or without a washer, and ingrowth or ongrowth surface designs will be at the discretion of the treating surgeon.

  • Nonoperative Care with Early RehabilitationOther

    Nonoperative care with early rehabilitation will consist of nonoperative treatment of the pelvis fracture, including early consultation of the physical therapist, physiotherapist, or local equivalent rehabilitation provider at the time of randomization for a first attempt at mobilization of the patient within 24 hours of randomization. Patients who are unable to ambulate with assistance after five or more days of attempted mobilization by rehabilitation providers may be considered for delayed internal fixation treatment at the discretion of the patient and the treating surgeon. Delayed internal fixation after five or more days of attempted mobilization by rehabilitation providers will not be considered a treatment crossover event.

Study groups in NCT06496867
Study groupRoleWhat they receive
Early Internal FixationExperimentalEarly internal fixation of the LC1 fragility fracture of the pelvis will be defined as percutaneous anterior and/or posterior pelvic internal fixation with cannulated screw(s), medullary implant(s), or sacroiliac joint fusion device(s).
Receives: Procedure: Early Internal Fixation
Nonoperative Care with Early RehabilitationActive comparatorNonoperative care with early rehabilitation will consist of nonoperative treatment of the pelvis fracture, including early consultation of the physical therapist, physiotherapist, or local equivalent rehabilitation provider at the time of randomization for a first attempt at mobilization of the patient within 24 hours of randomization
Receives: Other: Nonoperative Care with Early Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of participant enrollment

    Proportion of patients who provide informed consent

    Measured: 12 months post-randomization

  2. Feasibility of adherence to treatment allocation

    Proportion of Adherence to early internal fixation treatment allocation and nonoperative care with early rehabilitation treatment allocation

    Measured: 12 months post-randomization

  3. Refine data collection methods

    Proportion of participants with missing data for the primary composite outcome

    Measured: 12 months post-randomization

  4. Assess Protocol Compliance

    Proportion of randomization errors

    Measured: 12 months post-randomization

Secondary outcomes (1)
  1. Composite hierarchical outcome of mortality, ambulation, and health days at home.

    The secondary outcome (clinical primary outcome) will be a composite endpoint that will hierarchically assess its components in the following order: 1) mortality, 2) ambulation, and 3) healthy days at home. Mortality will consist of all causes of death. Ambulation will be defined as the ability of the patient to ambulate 10 feet or across the room a) without a walking aid or human assistance, b) with a waking aid and without human assistance, c) with human assistance, or d) unable to ambulate. Healthy days at home will be defined by subtracting the following measure components from the number of days in the time frame: mortality days, the total number of days spent in inpatient, observation, skilled nursing facilities (SNF), inpatient psychiatry, inpatient rehabilitation and long-term hospital settings as well as the number of outpatient emergency department and home health visits. The secondary outcomes will be assessed by a per-protocol analysis.

    Measured: 4 months post-randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2024
  2. Study start12 Nov 2024
  3. Primary completion21 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Why it stopped: Lower than expected enrollment rate

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06496867
Sponsor's protocol ID
HS-24-00309
Acronym
PIVOT-LC1-Pi
Status last verified
Aug 2026
First submitted
17 Jun 2024
Last updated
25 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Early Internal Fixation and Nonoperative Care with Early Rehabilitation in people with Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring and Fragility Fracture, run by University of Southern California at 13 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 25 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 13 sites in United States, Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of participant enrollment (time frame: 12 months post-randomization). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in